Hypoglycemia (low blood sugar level), Altered taste, Nausea, Diarrhoea, Stomach pain, Headache, Upper respiratory tract infection.
Diacron M 80 mg/500 mg Tablet is a combination of two antidiabetic medicines: Gliclazide and metformin. Gliclazide is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide which decreases the production and absorption of sugar in your body and allows better use of existing insulin. Together, they provide better control of blood sugar.
Alcohol
CAUTION
Taking metformin with alcohol can cause lactic acidosis and you may experience malaise, respiratory distress, slow or irregular heartbeat, sleepiness, stomach upset, or other unusual symptoms.
Pregnancy
WEIGH RISKS VS BENEFITS
Diacron M 80 mg/500 mg Tablet may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Lactation
Diacron M 80 mg/500 mg Tablet is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby.
Driving
Your ability to drive may be affected if your blood sugar is low or high. If this happens, do not drive.
Kidney
CAUTION
Diacron M 80 mg/500 mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Diacron M 80 mg/500 mg Tablet may be needed. Please consult your doctor.
Use of Diacron M 80 mg/500 mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Liver
CAUTION
Diacron M 80 mg/500 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Diacron M 80 mg/500 mg Tablet may be needed. Please consult your doctor.
Diacron M 80 mg/500 mg Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
